-
2020 Venture Funds Mixed, Biotech Keeps Sizzling
Total venture investments in dollars jumped to a new high in the U.S., while biotechnology remained the single hottest sector in 2020.
-
Infographic – US Public Down on Vaccine Rollout
Half or more of American adults express negative opinions about the way Covid-19 vaccines are distributed, according to a recent survey.
-
Registry Tracking Long-Term Covid-19 Impacts
A study now underway is tracking long-term effects of Covid-19 infections using real-world data from electronic sources provided by patients.
-
Universities Form Joint Engineering Patent Pool
A group of 15 American universities are putting part of their engineering patents into a common licensing pool for commercial development.
-
Micro-Robot Designed to Aid Internal Laser Surgery
An engineering team demonstrated a small robotic device that fits on current surgical equipment to improve laser surgery inside the body.
-
Five Methods That Lead To Productive Employees
Just by making small changes, you are able to drastically improve the productivity levels in your business.
-
Biotech Licenses mRNA Technology for Aging
A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging.
-
US Govt to Buy 1.25M Regeneron Covid-19 Therapies
The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion.
-
Drug Maker Gains Access to Hidden Protein Immunotherapies
Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells.
-
Moderna Developing Flu, HIV, Nipah Vaccines
Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases.